1-149791405-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000566.4(FCGR1A):āc.1013T>Cā(p.Ile338Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00424 in 1,599,558 control chromosomes in the GnomAD database, including 326 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000566.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00357 AC: 523AN: 146444Hom.: 20 Cov.: 26
GnomAD3 exomes AF: 0.00418 AC: 1019AN: 244050Hom.: 102 AF XY: 0.00409 AC XY: 542AN XY: 132610
GnomAD4 exome AF: 0.00431 AC: 6264AN: 1453008Hom.: 306 Cov.: 31 AF XY: 0.00422 AC XY: 3051AN XY: 722794
GnomAD4 genome AF: 0.00357 AC: 523AN: 146550Hom.: 20 Cov.: 26 AF XY: 0.00322 AC XY: 231AN XY: 71638
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | FCGR1A: PP2, BP4, BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at